Literature DB >> 31127603

Effect of Neonatal Phototherapy on Eosinophil Levels in Nonsevere Hyperbilirubinemia.

Ceren Can1, Şahin Hamilcıkan2.   

Abstract

OBJECTIVE: The purpose of the research was to determine the impact of phototherapy (PT) on eosinophil levels in neonates with nonsevere bilirubin levels (<20 mg/dL) treated with PT. STUDY
DESIGN: This observational pilot study included term neonates with early neonatal hyperbilirubinemia.
RESULTS: Ninety-six term neonates were included in the study. The male-to-female ratio was 1.23. Hyperbilirubinemia was most frequently related to ABO group incompatibility (49%). Fifty-two neonates (54.1%) were born by normal spontaneous delivery. After PT, while total serum bilirubin, hemoglobin, hematocrit, leukocyte, and neutrophil levels were found to be significantly decreased, eosinophil levels were significantly increased (p = 0.01). No significant difference was found regarding lymphocyte and basophil levels after PT. A statistically significant correlation was found between bilirubin and eosinophil levels before PT (r 2 = 0.28, p = 0.03). No correlation between eosinophil levels and treatment age, gender, diagnosis of hyperbilirubinemia, and delivery route before PT was found. After PT, eosinophil levels increased, while other blood cell series were found to be decreased. The correlation between the bilirubin levels and eosinophil was found to be negative (r 2 = - 0.32, p = 0.02) after PT.
CONCLUSION: PT may increase serum eosinophil levels in term neonates with nonsevere hyperbilirubinemia. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31127603     DOI: 10.1055/s-0039-1691746

Source DB:  PubMed          Journal:  Am J Perinatol        ISSN: 0735-1631            Impact factor:   1.862


  1 in total

1.  Eosinophil count and tumor necrosis factor α in response to phototherapy treatment of neonatal hyperbilirubinemia: a cross sectional study.

Authors:  Mai Rabie El-Sheikh; Amira Youssef Ahmed; Abd El-Rahman Mohamed ELMashad; Ibrahim Ibrahim Talaye; Eslam El-Sayed El-Hawary
Journal:  Ital J Pediatr       Date:  2022-06-20       Impact factor: 3.288

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.